Home › Stock analysis › APRE
Aprea Therapeutics (APRE) Stock: Why It's Down Today
Updated Oct 19, 2026, 4:00 PM ET · closing price
What changed since yesterday
- Closed at $0.53, -8.85% vs the prior close of $0.58.
- Volume 194.03K shares, 0.6x its 50-day average (light).
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
APRE slides 8.9% to $0.53, a 52-week low. Closed at $0.53, -8.85% vs the prior close of $0.58. Day range $0.53–$0.61, opened at $0.60.
Last close$0.53-8.85%
Day range0.53–0.61
Open0.60
Volume194.03K
52-week range0.53–1.69
Avg volume (20d)263.21K
APRE daily analysis — what happened
A plain-English, data-only note for every US trading day (today's note updates every 2 hours while the market is open). Newest first; older days stay archived below.
Oct 19, 2026 — APRE slides 8.9% to $0.53, a 52-week low
- Closed at $0.53, -8.85% vs the prior close of $0.58. Day range $0.53–$0.61, opened at $0.60.
- Volume was 194.03K shares, 0.6x its 50-day average of 348.51K — lighter than usual.
- Price is -26.4% vs its 50-day average ($0.72) and -30.9% vs its 200-day average ($0.77).
- 52-week range $0.53–$1.69; today's close sits at 0% of that range, 68.5% below the 52-week high.
Oct 16, 2026 — APRE slides 5.5% to $0.58
- Closed at $0.58, -5.47% vs the prior close of $0.62. Day range $0.57–$0.66, opened at $0.66.
- Volume was 160.10K shares, 0.5x its 50-day average of 345.76K — lighter than usual.
- Price is -19.5% vs its 50-day average ($0.73) and -24.3% vs its 200-day average ($0.77).
- 52-week range $0.55–$1.69; today's close sits at 3% of that range, 65.4% below the 52-week high.
Oct 15, 2026 — APRE jumps 6.0% to $0.62
- Closed at $0.62, +6.00% vs the prior close of $0.58. Day range $0.58–$0.63, opened at $0.58.
- Volume was 65.40K shares, 0.2x its 50-day average of 345.80K — lighter than usual.
- Price is -15.0% vs its 50-day average ($0.73) and -20.1% vs its 200-day average ($0.77).
- 52-week range $0.55–$1.69; today's close sits at 6% of that range, 63.4% below the 52-week high.
Oct 14, 2026 — APRE dips 2.8% to $0.58
- Closed at $0.58, -2.83% vs the prior close of $0.60. Day range $0.58–$0.61, opened at $0.61.
- Volume was 74.30K shares, 0.2x its 50-day average of 345.67K — lighter than usual.
- Price is -19.8% vs its 50-day average ($0.73) and -24.8% vs its 200-day average ($0.78).
- 52-week range $0.55–$1.69; today's close sits at 3% of that range, 65.5% below the 52-week high.
Oct 13, 2026 — APRE rises 1.2% to $0.60
- Closed at $0.60, +1.18% vs the prior close of $0.59. Day range $0.59–$0.65, opened at $0.61.
- Volume was 136.90K shares, 0.4x its 50-day average of 345.98K — lighter than usual.
- Price is -17.5% vs its 50-day average ($0.73) and -22.8% vs its 200-day average ($0.78).
- 52-week range $0.55–$1.69; today's close sits at 5% of that range, 64.5% below the 52-week high.
Oct 12, 2026 — APRE dips 1.8% to $0.59
- Closed at $0.59, -1.82% vs the prior close of $0.60. Day range $0.58–$0.62, opened at $0.61.
- Volume was 116.50K shares, 0.3x its 50-day average of 344.67K — lighter than usual.
- Price is -18.4% vs its 50-day average ($0.73) and -23.9% vs its 200-day average ($0.78).
- 52-week range $0.55–$1.69; today's close sits at 4% of that range, 64.9% below the 52-week high.
Oct 9, 2026 — APRE jumps 8.2% to $0.60
- Closed at $0.60, +8.24% vs the prior close of $0.56. Day range $0.56–$0.61, opened at $0.56.
- Volume was 70.40K shares, 0.2x its 50-day average of 343.63K — lighter than usual.
- Price is -17.0% vs its 50-day average ($0.73) and -22.6% vs its 200-day average ($0.78).
- 52-week range $0.55–$1.69; today's close sits at 5% of that range, 64.3% below the 52-week high.
Oct 8, 2026 — APRE slides 7.8% to $0.56, a 52-week low, 7 down days in a row
- Closed at $0.56, -7.77% vs the prior close of $0.61. Day range $0.55–$0.61, opened at $0.61.
- Volume was 239.40K shares, 0.7x its 50-day average of 341.61K.
- Price is -23.4% vs its 50-day average ($0.73) and -28.7% vs its 200-day average ($0.78).
- 52-week range $0.55–$1.69; today's close sits at 1% of that range, 67.0% below the 52-week high.
- That makes 7 straight losses.
Oct 7, 2026 — APRE slides 4.9% to $0.61, a 1-month low, 6 down days in a row
- Closed at $0.61, -4.87% vs the prior close of $0.64. Day range $0.58–$0.64, opened at $0.64.
- Volume was 249.90K shares, 0.7x its 50-day average of 338.32K.
- Price is -17.1% vs its 50-day average ($0.73) and -22.8% vs its 200-day average ($0.78).
- 52-week range $0.55–$1.69; today's close sits at 5% of that range, 64.2% below the 52-week high.
- That makes 6 straight losses.
Oct 6, 2026 — APRE slides 5.9% to $0.64, a 1-month low, 5 down days in a row
- Closed at $0.64, -5.92% vs the prior close of $0.68. Day range $0.63–$0.68, opened at $0.68.
- Volume was 198.90K shares, 0.6x its 50-day average of 334.72K — lighter than usual.
- Price is -12.8% vs its 50-day average ($0.73) and -19.1% vs its 200-day average ($0.79).
- 52-week range $0.55–$1.69; today's close sits at 8% of that range, 62.4% below the 52-week high.
- That makes 5 straight losses.
Oct 5, 2026 — APRE dips 2.7% to $0.68, a 1-month low, 4 down days in a row
- Closed at $0.68, -2.73% vs the prior close of $0.69. Day range $0.64–$0.69, opened at $0.69.
- Volume was 296.50K shares, 0.9x its 50-day average of 329.16K.
- Price is -7.3% vs its 50-day average ($0.73) and -14.1% vs its 200-day average ($0.79).
- 52-week range $0.55–$1.69; today's close sits at 11% of that range, 60.0% below the 52-week high.
- That makes 4 straight losses.
Oct 2, 2026 — APRE slides 4.0% to $0.69, a 1-month low on 2.8x normal volume
- Closed at $0.69, -4.01% vs the prior close of $0.72. Day range $0.69–$0.74, opened at $0.72.
- Volume was 862.20K shares, 2.8x its 50-day average of 312.53K — unusually heavy trading.
- Price is -4.6% vs its 50-day average ($0.73) and -11.8% vs its 200-day average ($0.79).
- 52-week range $0.55–$1.69; today's close sits at 13% of that range, 58.9% below the 52-week high.
- That makes 3 straight losses.
APRE bull case vs bear case (from the data)
Bull case
- Insiders made 16 open-market purchases in the last 12 months.
Bear case
- Price is -26.4% vs its 50-day average — short-term trend is down.
- Price is -30.9% vs its 200-day average — below the long-term trend line.
- Latest fiscal-year net income: loss of $12.60M.
- Share count up 116.1% in a year (dilution).
- High volatility: average daily move of 4.0% over 20 sessions.
- Thin trading (under $2M a day on average) can mean wide bid/ask spreads.
APRE latest news & SEC filings
Every SEC filing by or about APRE in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Aug 28, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Aug 13, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 12, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Net income: -$3.59M (prior year -$3.24M) (loss widened vs Jun 30, 2025)
- Diluted EPS: -$0.07 (prior year -$0.53) (loss narrowed vs Jun 30, 2025)
Aug 12, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
- Item 8.01 — Reported other events the company considers important.
This is a results-day filing: the earnings press release is attached as an exhibit.
Jul 23, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 3.01 — Stock exchange listing notice or transfer of listing.
Things to know before you trade APRE
- Last results release: Aug 12, 2026 (8-K Item 2.02). Previous ones: May 13, 2026, Mar 16, 2026, Nov 12, 2025. Based on that rhythm, the next report is likely around Nov 11, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 3.95% (largest 8.9%). That is a volatile stock.
- Liquidity: about 263.21K shares (≈$140.10K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $0.53 vs a range of $0.53–$1.69 (0% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 16 open-market buys, 0 sales; latest: John P. Hamill bought 5,700 shares on Jan 30, 2026.
- Latest filings: 8-K Aug 28, 2026; 10-Q Aug 12, 2026; 8-K Aug 12, 2026.
- Share count: 12.59M shares outstanding (Aug 12, 2026), +116.1% vs a year earlier — notable dilution.
- Listing: Nasdaq · industry: Pharmaceutical Preparations.
APRE market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 19, 2026 | 0.60 | 0.61 | 0.53 | 0.53 | 194.03K |
| Oct 16, 2026 | 0.66 | 0.66 | 0.57 | 0.58 | 160.10K |
| Oct 15, 2026 | 0.58 | 0.63 | 0.58 | 0.62 | 65.40K |
| Oct 14, 2026 | 0.61 | 0.61 | 0.58 | 0.58 | 74.30K |
| Oct 13, 2026 | 0.61 | 0.65 | 0.59 | 0.60 | 136.90K |
| Oct 12, 2026 | 0.61 | 0.62 | 0.58 | 0.59 | 116.50K |
| Oct 9, 2026 | 0.56 | 0.61 | 0.56 | 0.60 | 70.40K |
| Oct 8, 2026 | 0.61 | 0.61 | 0.55 | 0.56 | 239.40K |
| Oct 7, 2026 | 0.64 | 0.64 | 0.58 | 0.61 | 249.90K |
| Oct 6, 2026 | 0.68 | 0.68 | 0.63 | 0.64 | 198.90K |
| Oct 5, 2026 | 0.69 | 0.69 | 0.64 | 0.68 | 296.50K |
| Oct 2, 2026 | 0.72 | 0.74 | 0.69 | 0.69 | 862.20K |
| Oct 1, 2026 | 0.76 | 0.78 | 0.68 | 0.72 | 779.60K |
| Sep 30, 2026 | 0.78 | 0.82 | 0.74 | 0.75 | 581.70K |
| Sep 29, 2026 | 0.76 | 0.82 | 0.75 | 0.77 | 591.60K |
| Sep 28, 2026 | 0.76 | 0.77 | 0.74 | 0.75 | 69.80K |
| Sep 25, 2026 | 0.78 | 0.78 | 0.74 | 0.76 | 53.30K |
| Sep 24, 2026 | 0.80 | 0.80 | 0.76 | 0.78 | 52.00K |
| Sep 23, 2026 | 0.74 | 0.81 | 0.74 | 0.78 | 282.00K |
| Sep 22, 2026 | 0.76 | 0.76 | 0.70 | 0.73 | 189.60K |
About Aprea Therapeutics
Aprea Therapeutics (APRE) is listed on the Nasdaq and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in DOYLESTOWN, PA. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1781983.
APRE board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Jean-Pierre Bizzari | Director | Jun 17, 2026 |
| Marc Duey | Director | Jun 17, 2026 |
| Oren Gilad | President/CEO | Mar 16, 2026 |
| Michael Grissinger | Director | Jun 17, 2026 |
| Gabriela Gruia | Director | Jun 17, 2026 |
| John B Iii Henneman | Director | Jun 17, 2026 |
| Rifat Pamukcu | Director | Jun 17, 2026 |
| Richard Peters | Director | Jun 17, 2026 |
| Bernd R. Seizinger | Director | Jun 17, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Oren Gilad | President/CEO | Mar 16, 2026 |
| John P. Hamill | SrVP/CFO/Prin Fin & Acct Ofcr | Apr 1, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Jan 30, 2026 | John P. Hamill | Buy | 5,700 | $0.89 |
| Jan 30, 2026 | John P. Hamill | Buy | 5,700 | $0.89 |
| Jan 30, 2026 | John P. Hamill | Buy | 5,700 | $0.89 |
| Jan 30, 2026 | John P. Hamill | Buy | 5,700 | $0.89 |
| Jan 30, 2026 | Oren Gilad | Buy | 28,100 | $0.89 |
| Jan 30, 2026 | Oren Gilad | Buy | 28,100 | $0.89 |
| Jan 30, 2026 | Oren Gilad | Buy | 28,100 | $0.89 |
| Jan 30, 2026 | Oren Gilad | Buy | 28,100 | $0.89 |
| Dec 10, 2025 | Marc Duey | Buy | 21,459 | $1.17 |
| Dec 10, 2025 | Marc Duey | Buy | 21,459 | $1.17 |
| Dec 10, 2025 | Marc Duey | Buy | 21,459 | $1.17 |
| Dec 10, 2025 | Marc Duey | Buy | 21,459 | $1.17 |
| Dec 10, 2025 | John P. Hamill | Buy | 5,000 | $1.17 |
| Dec 10, 2025 | John P. Hamill | Buy | 5,000 | $1.17 |
| Dec 10, 2025 | John P. Hamill | Buy | 5,000 | $1.17 |
APRE financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | — | $-12.60M | -1.93 | $-12.89M |
| Dec 31, 2024 | — | $-12.96M | -2.35 | $-13.56M |
| Dec 31, 2023 | — | $-14.29M | -3.95 | $-12.18M |
| Dec 31, 2022 | — | $-112.66M | -67.99 | $-25.01M |
| Dec 31, 2021 | — | $-37.13M | -34.88 | $-37.69M |
Latest balance sheet: total assets $42.29M, total liabilities $3.95M, cash $41.23M (as of Jun 30, 2026).
APRE earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 12, 2026 | 8-K Item 2.02 (results) | $0.68 |
| May 13, 2026 | 8-K Item 2.02 (results) | $0.88 |
| Mar 16, 2026 | 8-K Item 2.02 (results) | $0.76 |
| Nov 12, 2025 | 8-K Item 2.02 (results) | $1.26 |
| Aug 12, 2025 | 8-K Item 2.02 (results) | $1.70 |
| May 14, 2025 | 8-K Item 2.02 (results) | $1.53 |
| Mar 25, 2025 | 8-K Item 2.02 (results) | $2.19 |
| Jan 13, 2025 | 8-K Item 2.02 (results) | $3.42 |
| Nov 7, 2024 | 8-K Item 2.02 (results) | $3.98 |
| Oct 9, 2024 | 8-K Item 2.02 (results) | — |
| Aug 12, 2024 | 8-K Item 2.02 (results) | — |
| May 14, 2024 | 8-K Item 2.02 (results) | — |
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)Merck (MRK)AbbVie (ABBV)Abbott Laboratories (ABT)Pfizer (PFE)Bristol Myers Squibb (BMY)Vertex Pharmaceuticals Inc / Ma (VRTX)Regeneron Pharmaceuticals (REGN)Novo Nordisk A S (NVO)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)AMD (AMD)Microsoft (MSFT)Intel (INTC)Amazon (AMZN)
More on APRE
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 19, 2026, 4:00 PM ET. Filings: SEC EDGAR. Refreshed every 2 hours during US market hours.